Digital Diabetes Management Market Size - By Product Type (Devices, Services), By Patient Type (Type 1, Type 2), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics)

Description

List of Tables

Global Digital Diabetes Management Market size will expand exponentially through 2032. Growing healthcare expenditure towards diabetes is the key factor positively impacting the industry growth. Increasing global burden of diabetes has compelled many governments across the world to invest considerable amounts into digital diabetes management solutions for remote patient monitoring. In fact, many governments have also implemented favorable reimbursement policies for advanced diabetes management devices, which will further shape the industry landscape. Business behemoths in the space are emphasizing developing advanced diagnostic devices to strengthen their position, opening new growth avenues for the market.

The overall digital diabetes management market is categorized based on product, patient, end-use, and region.

In terms of product, digital diabetes management devices market value will depict considerable gains through 2032. Rising occurrence of diabetes, coupled with the surging inclination of people towards a personalized approach to diabetes care, has increased the demand for digital diabetes management devices. Additionally, these devices offer convenience and ease of use, making it simpler for individuals to monitor their blood glucose levels and manage their diabetes daily.

Based on patient, industry size from the type 1 segment will grow at over 19% CAGR from 2023 to 2032. Surging prevalence of type 1 diabetes has increased the adoption of digital diabetes management solutions. In fact, mobile apps for glucose monitoring, nutrition control, insulin titration, and insulin delivery have become increasingly popular among type 1 diabetic people for health tracking. Moreover, this demographic is highly dependent on insulin, which has increased the adoption of insulin-delivery devices.

Based on end-use, industry value from the diagnostic centers & clinics segment will witness significant gains through 2032. High availability of advanced insulin delivery devices has increased patient visits to diagnostic centers & clinics. Many diagnostic centers now offer seamless integration with digital platforms and electronic health record systems. This integration allows individuals to receive their test results digitally, view trends over time, and easily share data with their healthcare providers or digital diabetes management applications.

Regionally, Europe digital diabetes management market size will reach USD 32 billion by 2032. Growing incidence of diabetes in countries such as Germany, France, Italy, and Spain has increased the adoption of digital diabetes management solutions in the region. Moreover, regional expansion can also be attributed to the presence of leading industry giants such as F. Hoffmann-La Roche Ltd and others emphasizing product innovations to retain their industry standing.

Product Code: 4903

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data Validation
1.5 COVID-19 impact analysis at regional level
1.6 Data Sources
- 1.6.1 Secondary
  - 1.6.1.1 Paid sources
  - 1.6.1.2 Public sources
- 1.6.2 Primary

Chapter 2 Executive Summary

2.1 Digital diabetes management industry 360 degree synopsis, 2018 - 2032 (USD Million)
2.2 Business trends
2.3 Regional trends
2.4 Product type trends
2.5 Patient type trends
2.6 End-use trends

Chapter 3 Digital Diabetes Management Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising number of people suffering from diabetes
  - 3.2.1.2 Advent of artificial intelligence and big data analytics in diabetes devices
  - 3.2.1.3 Rising healthcare expenditure towards diabetes
  - 3.2.1.4 Growing awareness about technologically advanced products
  - 3.2.1.5 Favorable reimbursement policies
  - 3.2.1.6 Rising number of product launches
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of advanced devices
3.3 Growth potential analysis
- 3.3.1 By product type
- 3.3.2 By patient type
- 3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
- 3.5.1 U.S.
- 3.5.2 Europe
- 3.5.3 China
3.6 Reimbursement scenario
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive dashboard, 2022
4.4 Company market share analysis, 2022
4.5 Vendor matrix analysis, 2022
4.6 Competitive analysis of major market players
4.7 Competitive positioning matrix
4.8 Strategic outlook matrix

Chapter 5 Digital Diabetes Management Market Size and Forecast, By Product Type (USD Million)

5.1 Key trends, by product type
5.2 Devices
- 5.2.1 By device
  - 5.2.1.1 Smart blood glucose meters
  - 5.2.1.2 Smart CGM
  - 5.2.1.3 Smart insulin pumps and patches
  - 5.2.1.4 Smart insulin pens
- 5.2.2 By device type
  - 5.2.2.1 Handheld
  - 5.2.2.2 Wearable
5.3 Services
- 5.3.1 Software
- 5.3.2 Apps

Chapter 6 Digital Diabetes Management Market Size and Forecast, By Patient Type (USD Million)

6.1 Key trends, by patient type
6.2 Type 1
6.3 Type 2

Chapter 7 Digital Diabetes Management Market Size and Forecast, By End-use (USD Million)

7.1 Key trends, by end-use
7.2 Hospitals
7.3 Home settings
7.4 Diagnostic centers & clinics
7.5 Others

Chapter 8 Digital Diabetes Management Market Size and Forecast, By Region (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 India
- 8.4.3 Japan
- 8.4.4 Australia
- 8.4.5 South Korea
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Colombia
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE

Chapter 9 Company Profiles

9.1 Abbott Laboratories
9.2 Medtronic Plc
9.3 F.Hoffmann-La Roche Ltd
9.4 Dexcom, Inc
9.5 Senseonics
9.6 Insulet Corporation
9.7 Tandem Diabetes Care, Inc
9.8 Ypsomed Holding
9.9 Ascensia Diabetes Care Holdings Ag
9.10 Tidepool
9.11 Glooko Inc
9.12 DarioHealth Corporation
9.13 Novo Nordisk A/S
9.14 Pendiq
9.15 Emperra GmbH E-Health Technologies